Pub. L. 117-215, sec. 1 (as amended)
SHORT TITLE; TABLE OF CONTENTS.
SECTION 1. [21 U.S.C. 801 note] SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.—This Act may be cited as the “Medical Marijuana and Cannabidiol Research Expansion Act”.
(b) Table of Contents.—The table of contents for this Act is as follows:
Sec. 1. Short title; table of contents.
Sec. 2. Definitions.
Sec. 3. Determination of budgetary effects.
TITLE I—REGISTRATIONS FOR MARIJUANA RESEARCH
Sec. 101. Marijuana research applications.
Sec. 102. Research protocols.
Sec. 103. Applications to manufacture marijuana for research.
Sec. 104. Adequate and uninterrupted supply.
Sec. 105. Security requirements.
Sec. 106. Prohibition against reinstating interdisciplinary review process for non-NIH-funded researchers.
TITLE II—DEVELOPMENT OF FDA-APPROVED DRUGS USING CANNABIDIOL AND MARIJUANA
Sec. 201. Medical research on cannabidiol.
Sec. 202. Registration for the commercial production and distribution of Food and Drug Administration-approved drugs.
TITLE III—DOCTOR-PATIENT RELATIONSHIP
Sec. 301. Doctor-patient relationship.
TITLE IV—FEDERAL RESEARCH
Sec. 401. Federal research.
- Cross-references to the US Code
- 21 U.S.C. 801 note